Hacking the vagal system to treat chronic cough
The Pharmaceutical Journal from the Royal Pharmaceutical Society
Source: pharmaceutical-journal.com
Stay updated with breaking news from Surinder Birring. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Pharmaceutical Journal from the Royal Pharmaceutical Society
British researchers found gefapixant reduces coughing by 60 per cent, improves chronic sufferers' sleep and reduces chest pain. It would be the first new cough treatment in 50 years if approved.
Lung doctor says Gefapixant could be first new treatment for condition to be approved in UK for more than 50 years